NGOZI UGWU: Open Payments
NPI 1184026684 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 18 payments from 9 companies in 2025. Trend: 2023 $667 · 2024 $352 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $76 |
| ABBVIE INC. | 3 | $75 |
| Alkermes, Inc. | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Lundbeck LLC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: INVEGA SUSTENNA, VRAYLAR, ARISTADA, TRINTELLIX, CAPLYTA, Jornay PM, REXULTI, ABILIFY ASIMTUFII.
Industry payments across NV — which companies pay providers there.
